PharmaShots | Incisive News in 3 Shots

Subscribe Now

Apabetalone

Resverlogix Receives the US FDA Breakthrough Therapy Designation for Apabetalone

Resverlogix Receives the US FDA Breakthrough Therapy Designation for Apabetalone

February 3, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us